Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma
Titel:
Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma
Auteur:
Hjelm Skog, A.-L. Ragnhammar, P. Fagerberg, J. Frödin, J.-E. Goldinger, M. Koldestam, H. Liljefors, M. Nilsson, B. Shetye, J. Wersäll, P. Mellstedt, H.